A Spotlight on PAT: 4 Critical Updates by GSK, Explicat Pharma, De Montfort University and RheaVita BV
Lyophilisation Europe is part of SMi’s Global Lyophilisation series of events and will take place on 4th and 5th July in Central London.
London, United Kingdom, May 12, 2016 --(PR.com)-- As well as being supported by leading scientific experts in the area of drug formulation and featuring an international panel of senior freeze drying experts and drug manufacturers, SMi’s 4th annual conference, Lyophilisation Europe, will include a dedicated spotlight on the latest in Process Analytical Technology (PAT) with FOUR exclusive presentations and a panel debate on evolving key developments.
The Use Of Pat Tools And Statistical Analysis To Determine Optimal Freeze Drying Cycle Parameters For Scale-Up
Erwan Bourles, Freeze Dryer Scientist, GSK
Select accurate process parameters to preserve product from collapse as GSK unveil: how to analyse surface response to create a process acceptable range for the selected freeze drying cycle; how to validate acceptable ranges with experimental trials using PAT tools.
Modern Process Of Lyophilisation
Andrea Weiland, Pharmacist, Ph.D.Managing Director, Explicat Pharma GmbH
Learn how to modernise your process through evaluating current lyophilisation processes and receiving progressive updates into real time PAT control.
Through Vial Impedance Spectroscopy : A PAT To Develop A Rational Lyophilization Cycle
Geoff Smith, Professor of Pharmaceutical Process Analytical Technology, De Montfort University
Discover how to overlap PAT from single vial to batch monitoring and address key questions with our scientific expert: What are the challenges inherent to the pre-formulation and phases transitions during lyophilisations? What should be classed as critical process parameters? What happens on microscale-down and scale up?
Continuous Freeze Drying Of (Bio-) Pharmaceuticals
Jos Corver, Founder, RheaVita BV
Discover the latest developments in PAT with a focus on continuous freeze drying and overcoming common obstacles.
This is just a snapshot of what will be covered on the programme for 2016. A detailed agenda featuring further presentations from GSK Vaccines, NIBSC, Sanofi, Novo Nordisk, Boehringher Ingelheim and more, is available online at www.lyophilisation-europe.com
Lyophilisation Europe
4th & 5th July 2016
Holiday Inn Kensington Forum, London UK
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
The Use Of Pat Tools And Statistical Analysis To Determine Optimal Freeze Drying Cycle Parameters For Scale-Up
Erwan Bourles, Freeze Dryer Scientist, GSK
Select accurate process parameters to preserve product from collapse as GSK unveil: how to analyse surface response to create a process acceptable range for the selected freeze drying cycle; how to validate acceptable ranges with experimental trials using PAT tools.
Modern Process Of Lyophilisation
Andrea Weiland, Pharmacist, Ph.D.Managing Director, Explicat Pharma GmbH
Learn how to modernise your process through evaluating current lyophilisation processes and receiving progressive updates into real time PAT control.
Through Vial Impedance Spectroscopy : A PAT To Develop A Rational Lyophilization Cycle
Geoff Smith, Professor of Pharmaceutical Process Analytical Technology, De Montfort University
Discover how to overlap PAT from single vial to batch monitoring and address key questions with our scientific expert: What are the challenges inherent to the pre-formulation and phases transitions during lyophilisations? What should be classed as critical process parameters? What happens on microscale-down and scale up?
Continuous Freeze Drying Of (Bio-) Pharmaceuticals
Jos Corver, Founder, RheaVita BV
Discover the latest developments in PAT with a focus on continuous freeze drying and overcoming common obstacles.
This is just a snapshot of what will be covered on the programme for 2016. A detailed agenda featuring further presentations from GSK Vaccines, NIBSC, Sanofi, Novo Nordisk, Boehringher Ingelheim and more, is available online at www.lyophilisation-europe.com
Lyophilisation Europe
4th & 5th July 2016
Holiday Inn Kensington Forum, London UK
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Teri Arri
+44 (0) 207 827 6000
http://www.lyophilisation-europe.com/prcom
Teri Arri
+44 (0) 207 827 6000
http://www.lyophilisation-europe.com/prcom
Contact
Categories